Pharmacogenomics

Article	Citations
Identification of RNA Modification-Associated Single-Nucleotide Polymorphisms in Genomic Loci for Low-Density Lipoprotein Cholesterol Concentrations	36
Pharmacogenomics in Psychiatry – the Challenge of Cytochrome P450 Enzyme Phenoconversion and Solutions to Assist Precision Dosing	27
Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization	26
miR-369-3p regulates the drug resistance of lung cancer cells by targeting PTPN12	23
Assessing the Utility of Measurement Methods Applied in Economic Evaluations of Pharmacogenomics Applications	22
A systematic review of single nucleotide polymorphisms affecting allopurinol pharmacokinetics and serum uric acid level	22
Severe systemic Adverse Reactions to Ophthalmic Timolol in a CYP2D6 Homozygous *4 Allele Carrier: A Case Report	21
Pharmacogenetics of Sulfonylurea-Induced Hypoglycemia in Type 2 Diabetes Patients: the SUCLINGEN Study	21
Rapid point of care testing: the next frontier in pharmacogenomics	19
Integrated in a Systems Pharmacology Approach, Pharmacogenetics holds the Promise for Personalized Medicine in Neonates	17
Characterization of CYP2C19 Pharmacogenetic Variation in African Populations and Comparison with Other Global Populations	17
Contrasting ABCB1 Pharmacogenetics and Psychotropic Responses in Child and Adolescent Psychiatry: A case comparison	16
CYP2D6 Gene Resequencing in the Malagasy, a Population at the Crossroads between Asia and Africa: A Pilot Study	14
Gene Polymorphisms Affect Postoperative Imatinib Plasma Levels and Edema in Adults With Gastrointestinal Stromal Tumor	14
A Survey of Physician Opinions in Russia in the Field of Pharmacogenetics of Cardiovascular Disease	12
Pharmacogenetic markers and macrolide safety in influenza patients: insights from a prospective study	12
Workforce readiness for pharmacogenomics and key elements for sustainment within the Veterans Health Administration	12
Multiple Genetic Mutations Increase the Risk of Thrombosis Associated With Clopidogrel After Percutaneous Coronary Intervention	11
Genetic polymorphisms and adverse reactions to antituberculosis therapy	11
Pharmacogenomics and rare diseases: optimizing drug development and personalized therapeutics	11
EFfects of UGT1A , CYP2C9/19 and ABAT Polymorphisms on Plasma Concentration of Valproic Acid in Chinese Epi	11
Association of NAT-2 Gene Polymorphisms Toward Lung Cancer Susceptibility and Prognosis in North Indian Patients Treated with Platinum-Based Chemotherapy	11
Cost–Effectiveness of HLA-B*58:01 Testing to Prevent Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis in Vietnam	10
The Promise�of Digital Health in Healthcare Equity and Medication Adherence in the Disadvantaged Dementia Population	10
The cost–effectiveness of zolbetuximab in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma	10

Improving the Management of ALK-Rearranged Non-Small-Cell Lung Cancer Through a Mobile Application: A Physicians-Based Survey	10
UGT1A1 Genotype-Guided Dosing of Irinotecan: Time to Prioritize Patient Safety	10
Methods for Actionable Gene Fusion Detection in Lung Cancer: Now and in the Future	10
A critical review of RAF inhibitors in BRAF-mutated glioma treatment	9
Impact of genetic variants on fentanyl metabolism in major breast surgery patients: a candidate gene association study	9
Genetic Factors Associated with Tuberculosis-Related Clinical Outcomes in HIV-Infected Black African Patients: a Systematic Review and Meta-Analysis	9
Accuracy and technical characteristics of CYP2C19 point of care tests: a systematic review	8
The Festival of Genetics and Personalized Medicine	8
Effects of CYP3A4 and CYP2C9 Genotype on Systemic Anastrozole and Fulvestrant Concentrations in SWOG S0226	8
Genetika+: Precision Medicine Solutions for Mental Health	8
Carbamazepine Cutaneous Adverse Reactions and HLA Gene Variation in the Chinese Population: A Systematic Review and Meta-Analysis	8
Head-to-head Comparison of Various Antipsychotic Agents on Genome-Wide Methylation in Schizophrenia	8
TPMT and NUDT15 genotyping, TPMT enzyme activity and metabolite determination for thiopurines therapy: a reference laboratory experience	8
Estimated clinical utility of multi-gene pharmacogenetic testing in a retrospective cohort of gynecology patients	7
SLCO1B1 and ABCB1 Variants Synergistically Influence the Atorvastatin Treatment Response in South Indian Coronary Artery Disease Patients	7
Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations	7
Predicting laboratory aspirin resistance in Chinese stroke patients using machine learning models by GP1BA polymorphism	7
DDX11-AS1 Modulates Dna Damage Repair to Enhance Paclitaxel Resistance of Lung Adenocarcinoma Cells	7
Association between CYP3A4 , CYP3A5 and ABCB1 Genotype and Tacrolimus Treatment Outcomes Among Allogeneic H	7
Barriers and facilitators for implementing a pharmacogenetic passport: lessons learned from reusing sequencing data	7
Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case–control study	6
Donor-Derived Cell Free DNA as a Biomarker in Kidney Transplantation	6
XDH Genotypes Through Gene–Gene Interactions with NUDT15 Affect Azathioprine-Induced Leukopenia in Chinese Patients	6
Polymorphisms of Genes Related to Phase II Metabolism and Resistance to Clopidogrel	6
Knowledge and Attitudes of Incoming Pharmacy Students Toward Pharmacogenomics and Survey Reliability	6
Exploring the Potential Benefits of Pharmacogenomics in Chronic Respiratory Diseases	6
Erratum	6
Glutathione S -transferase Gene Polymorphism and Asthma: A Case–Control Study in a Pediatric Population	6
Pharmacogenomics in Pediatric Medicine and Drug Development	6
DPYD Genotyping and Predicting Fluoropyrimidine Toxicity: Where do we Stand?	6
Impact of ABCB1 gene polymorphism on clopidogrel plasma concentration and cardiovascular events in post-PCI patients	5
Pharmacogenomic curriculum in Australian medical schools: a content analysis study	5
Pharmacogenomics: A Tool to Improve Medication Safety and Efficacy in Patients with Cystic Fibrosis	5
Patient Satisfaction With Return of Pharmacogenomic Results Utilizing a Patient Portal Message	5
Impact of CYP2C19 Gene Polymorphisms on Warfarin Dose Requirement: A Systematic Review and Meta-Analysis	5
The Frequency Of Rs2231142 in ABCG2 Among Native Hawaiian nd Pacific Islander Subgroups: Implications for Personalized Rosuvastatin Dosing	5
Relevance of NAT2 Genotype and Clinical Factors to Risk for Antituberculosis Drug-Induced Liver Injury	5
Overview of the Year 2023 at Pharmacogenomics	5
Posttransplantation diabetes mellitus (PTDM): pharmacological aspects and genetic predispositions	5
Bioinformatic Tools are Essential to Integrating Pharmacogenomics into Clinical Practice: Lessons from Neuropsychiatric Disorders	5
The Effects of Sex on Pharmacogenetically Guided Drug Treatment	5
The Revolution of Pharmaco-Omics: Ready to Open new Avenues in Materializing Precision Medicine?	5
Dosage Optimization of Clopidogrel Via a Precision Medicine Approach: The Way Forward	5
Pharmacogenomic Study of Anthracycline-Induced Cardiotoxicity in Mexican Pediatric Patients	5
Polymorphisms in the CYP3A5 Gene Significantly Affect the Pharmacokinetics of Sirolimus After Kidney Transplantation	5
Genetic polymorphisms of OPRM1 on the Efficacy and Safety of Anesthetic and Analgesic Agents: A Systematic Review	5
The Genetics of Drug-Induced Qt Prolongation: Evaluating the Evidence for Pharmacodynamic Variants	5
Relevance of NR1I2 Variants on Carbamazepine Therapy in Mexican Mestizos with Epilepsy at a Tertiary-Care Hospital	5
Influence of CYP3A5 , IL-10 Polymorphisms and Metabolism Rate on Tacrolimus Exposure in Renal Post-Transplant Recipients	5
Clinical Pharmacology and Pharmacogenomics for Implementation of Personalized Medicine	4

Effect of UGT1A6 and UGT2B7 polymorphisms on the valproic acid serum concentration and drug-induced liver injury	4
lncRNA MALAT1 Regulates the Resistance of Breast Cancer Cells to Paclitaxel Via the miR-497-5p/ SHOC2 axis	4
The Importance of Phenoconversion when using the CYP2D6 Genotype in Clinical Practice	4
Pharmacogenomics Implementation: “ A Little Less Conversation, a Little More Action, Please ”	4
Healthcare Professionals’ Knowledge, Confidence and Perceptions of Pharmacogenomics in Primary Care and Pain Management	4
Engaging Pharmacogenomics in Pain Management and Opioid Selection	4
Leveraging Clinical Decision Support to Reduce the Risk of Discordant Pharmacogenomics Results	4
Genome-Wide Association Study of Liver Enzyme Elevation in an Extended Cohort of Rheumatoid Arthritis Patients Starting Low-Dose Methotrexate	4
Association of CYP2C19 , CYP3A4 and ABCC2 Polymorphisms and Voriconazole Plasma Concentrations in Uygur Ped	4
Pharmacogenomics education among professional societies: assessing practices and future needs	4
Pharmacogenomic Prescribing Opportunities in Percutaneous Coronary Intervention and Bone Marrow Transplant Patients	4
Single-Nucleotide Polymorphisms in ABC Drug Transporters Alter Expression and Circulating Tenofovir in Healthy South African Women Exposed to Pre-Exposure Prophylaxis	4
Influence of Polymorphisms in CYP2C9 , VKORC1 , MDR1 and APOE Genes on the W	4
Congruence Rates for Pharmacogenomic Noninterruptive Alerts	4
Pharmacogenetics of HIV Therapy: Challenges for Tailoring Treatment in Genetically Complex Populations	4
SLCO1B3 Polymorphisms and Clinical Outcomes in Kidney Transplant Recipients Receiving Mycophenolate	4
Evaluation of Pentamidine Tolerability and Efficacy Between CYP2C19 Phenotypes	4
ATP Binding Cassette Transporters and Cancer: Revisiting Their Controversial Role	4
KCNQ1 Variant rs163184 is a Potential Biomarker of Glycemic Response to Exenatide	4
Pharmacogenetics of Calcineurin inhibitors in kidney transplant recipients: the African gap. A narrative review	4
Artificial intelligence, medications, pharmacogenomics, and ethics	4
Psychiatric Level 1A Evidence Pharmacogenomics in a Brazilian Admixed Cohort and Global Populations	4
Effects of immunorelated gene polymorphisms on trastuzumab targeting breast cancer cell in vitro	3
SLCO1B3 T334G Polymorphisms and Mycophenolate Mofetil-Related Adverse Reactions in Kidney Transplant Recipients	3
Evaluation of the Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) Clinical Program at Initial Test Sites	3
Pharmacogenomic Testing to Support Prescribing in Primary Care: a Structured Review of Implementation Models	3
Pharmacoepigenomics: A Key Determinant in Resolving Epigenomic Parameters in Pathogenesis and Treatment Response in Complex Diseases	3
Validation of a Multi-Gene qPCR-Based Pharmacogenomics Panel Across Major Ethnic Groups in Singapore and Indonesia	3
Pharmacogenomic Variants Affecting Efficacy and Toxicity of Statins in a South Asian Population from Sri Lanka	3
Integrating Pharmacogenomic Testing Into Paired Germline and Somatic Genomic Testing in Patients with Cancer	3
Implication of KDM6A in Bladder Cancer	3
The Need to Shift Pharmacogenetic Research from Candidate Gene to Genome-Wide Association Studies	3
Pharmacogenetics Research in Brazil: A Systematic Review	3
Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada	3
Analysis of the Difference in SLCO1B1 and APOE Gene Polymorphisms Between Mongolian and Han Populations	3
Effects of the CYP2C19 LoF Allele on Major Adverse Cardiovascular Events Associated with Clopidogrel in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary	3
Pharmacogenetic Informed Care in Early Childhood: Options for Improving Access and Health Equity	3
Effects of genetic and clinical factors on thiopurine drugs pharmacokinetics in Tunisian patients	3
The Sixth European Society of Pharmacogenomics and Personalised Therapy Congress	3
Reinterpretation of pharmacogenomic phenotypes after combinatorial psychiatric testing	3
Premarket Assessment of Molecular Alterations in Drug Targets: A Case Study of 2020 Drug Approvals	3
Evaluation of pharmacogenetic automated clinical decision support for clopidogrel	3
Pilot Study of Multi-Gene Pharmacogenetic Testing for Pain Management in Oncology Palliative Medicine	3
Genetic Variants of the Nuclear Factor Erythroid 2-Related Factor 2/Antioxidant Reaction Element Pathway on the Risk of Antituberculosis Drug-Induced Liver Injury: A Systematic Review	3
Targeting RET mutation in medullary thyroid cancer	3
Pharmacogenetic Variants Influence Vitamin K Anticoagulant Dosing in Patients with Mechanical Prosthetic Heart Valves	3
Use of a Consultation Service Following Pharmacogenetic Testing in Psychiatry	3
ABCB1 and OPRM1 Single-Nucleotide Polymorphisms Collectively Modulate Chronic Shoulder Pain and Dysfunction in South African Breast Cancer Survivors	3
Attitudes about Pharmacogenomic Testing Vary by Healthcare Specialty	2
Challenges for the Application of Pharmacogenomics Associated with the Nomenclature of Allelic Variants	2
Application of Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma	2
Pharmacogenetic and Pharmacogenomic Treatment of Rheumatoid Arthritis: A Review of Pharmacogenomics Knowledge Base Scientific Evidence	2
Impact of the PEAR 1 Polymorphism on Clinical Outcomes in Chinese Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Interventio	2
Warfarin Pharmacogenomics in African Populations: The Importance of Ethnicity-Based Algorithms	2
Comparing the clinical utility of pharmacogenomic genotyping and next generation sequencing in a military health system adult medicine clinic	2
Pharmacogenetic Loci for Rosuvastatin are Associated with Intima-Media Thickness Change and Coronary Artery Disease Risk	2
SALL4 upregulates brain-derived neurotrophic factor to mediate Hedgehog signaling to inhibit carboplatin sensitivity in colon adenocarcinoma	2
Association of Polymorphisms in ARRB2 and Clinical Response to Methadone for Pain in Advanced Cancer	2
Effects of MDR1 and OPRM1 Genetic Polymorphisms on the Pharmacodynamics of Propofol–Remifentanil TIVA in Pediatrics	2
Could Pharmacogenetics Aid the Prediction of NeviRapine Pharmacokinetics and Allow Individualized Treatment?	2
Association Between Genetic Variants and the Risk of Nivolumab-Induced Immune-Related Adverse Events	2
Personalized Anti-Rejection Therapy with Alemtuzumab for Kidney Transplant Recipients	2
Pharmacogenomics of Medications Given Via Nonconventional Administration Routes: A Scoping Review	2
The Effect of CYP2C19 Gene Polymorphism on the Eradication Rate of Helicobacter Pylori by Proton Pump Inhibitors-ContAining Regimens in As	2
HLA Pharmacogenetic Markers of Drug Hypersensitivity from the Perspective of the Populations of the Greater Middle East	2
TPMT Gene Polymorphisms (c.238G>C, c.460G>A and c.719A>G) in a Healthy Venezuelan Population	2
Genetic Factors in Treatment-Related Cardiovascular Complications in Survivors of Childhood Acute Lymphoblastic Leukemia	2
Treatment of extended RAS/ BRAF wild-type metastatic colorectal cancer with anti-EGFR antibody combinations	2
Polymorphism of CYP3A4*18 is associated with anti-tuberculosis drug-induced hepatotoxicity	2
Breast Cancer Pharmacogenetics: A Systematic Review	2
Antiplatelet Therapy Guided by CYP2C19 Point-of-Care Pharmacogenetics Plus Multidimensional Treatment Decisions	2
Identification of Clinical and Pharmacogenetic Factors Influencing Metformin Response in Type 2 Diabetes Mellitus	2
Progression of Precision Statin Prescribing for Reduction of Statin-Associated Muscle Symptoms	2
Pharmacogenetic Differentiation Across Latin America	2
Pharmacogenomics and Clinical Cultural Competency: Pathway to Overcome the Limitations of Race	2
Genome-Wide Association Study of Liver Enzyme Elevation in Rheumatoid Arthritis Patients Starting Methotrexate	2
Impact of CYP2C19 polymorphism testing on the risk of stent thrombosis in patients with carotid artery stenting	2
Pharmacogenomics in Clinical Practice to Prevent Risperidone-Induced Hyperprolactinemia in Autism Spectrum Disorder	2
An Interview with Dr Chiara Fabbri: Pharmacogenomics and Drug Repurposing for Treatment-Resistant Depression	2
Application of Pharmacogenomics in Supportive Oncology: A Patient Journey	2

The genomic landscape of CYP2D6 variation in the Indian population	2
Pharmacogenomic markers associated with drug-induced QT prolongation: a systematic review	2
Parental Understanding and Attitudes Following Pharmacogenomic Testing for Pediatric Neuropsychiatric Patients	2
Pharmacogenetics of 6-Mercaptopurine in a Black Zimbabwean Cohort Treated for Acute Lymphoblastic Leukaemia	2
IL16 and Factor V Gene Variations are Associated with Asparaginase-Related Thrombosis in Childhood Acute Lymphoblastic Leukemia Patients	2
Pharmacogenomics of Hydroxyurea Therapy and Fetal Hemoglobin Levels in Sickle Cell Anemia	2
Whole-exome Sequencing Reveals Novel Candidate Single Nucleotide Variations for Preventing Adverse Effects of Levonorgestrel Implantation	2
Substrate Specificity of CYP2D6 Genetic Variants	2
Considering Medication Exposure in Genomic Association Studies of Cognition in Psychotic Disorders	2